
ACET
Adicet Bio Inc.
$0.82
+$0.03(+3.26%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$66.17M
Volume
267.04K
52W Range
$0.45 - $1.54
Target Price
$6.00
Order:
Income Statement
Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
Total Revenue | -- | $995.0K | $17.9M | $9.7M | $704.0K | $714.0K | $727.0K | ||
Total Revenue | -- | $995.0K | $17.9M | $9.7M | $25.0M | $714.0K | $727.0K | ||
COST OF GOODS SOLD | |||||||||
Cost of Revenue | $-39.7M | $-85.5M | -- | -- | -- | -- | -- | ||
GROSS PROFIT | |||||||||
Gross Profit | $39.7M | $995.0K | $17.9M | $9.7M | $704.0K | $714.0K | $727.0K | ||
OPERATING EXPENSES | |||||||||
Operating Expenses | $-23.1M | $-32.4M | $57.1M | $71.2M | $97.5M | $152.0M | $127.6M | ||
Research & Development | $31.1M | $23.7M | $34.3M | $48.9M | $71.2M | $106.0M | $99.3M | ||
Research Expense | $31.1M | $23.7M | $34.3M | $48.9M | $71.2M | $106.0M | $99.3M | ||
Selling, General & Administrative | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | ||
General & Administrative Expenses | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | ||
Salaries & Wages | $-2.8M | $-1.2M | -- | -- | -- | $20.3M | $22.2M | ||
Depreciation & Amortization | $-80.0K | $-1.2M | $1.2M | $1.5M | $2.6M | $6.1M | $6.5M | ||
Depreciation & Amortization | $-80.0K | $-1.2M | $1.2M | $1.5M | $2.6M | $6.1M | $6.5M | ||
Amortization | -- | -- | $20.1M | $19.5M | $19.5M | -- | -- | ||
Other Operating Expenses | -- | -- | $950.0K | $4.3M | $4.5M | $-598.0K | $-221.0K | ||
OPERATING INCOME | |||||||||
Operating income | $-39.7M | $-31.4M | $-39.2M | $-61.4M | $-72.6M | $-152.0M | $-127.6M | ||
EBITDA | $-10.5M | $-27.1M | $-38.1M | $-60.4M | $-67.1M | $-136.5M | $-110.7M | ||
NON-OPERATING ITEMS | |||||||||
Interest Expense (Non-Operating) | -- | -- | $134.0K | $176.0K | $80.0K | $25.0K | $4.0K | ||
Interest Income Operating | -- | -- | -- | -- | -- | $10.0M | $10.7M | ||
Intinc | -- | $938.0K | $785.0K | $91.0K | $3.8M | $10.0M | $10.7M | ||
Net Non-Operating Interest Income/Expense | -- | $938.0K | $651.0K | $-85.0K | $3.7M | $10.0M | $10.7M | ||
Gain on Sale of Securities | $2.1M | $2.8M | -- | -- | -- | -- | -- | ||
Other Income/Expense | $-2.1M | $-2.3M | $953.0K | $606.0K | $-919.0K | $573.0K | $217.0K | ||
Other Special Charges | $-7.0K | $2.3M | $-953.0K | $-606.0K | $24.1M | $-573.0K | $-217.0K | ||
SPECIAL ITEMS | |||||||||
Restructring And Mn A Income | -- | $113.2M | $35.8M | -- | -- | -- | -- | ||
Special Income Charges | -- | $-113.2M | $-35.8M | -- | -- | $-19.5M | -- | ||
Impairment of Capital Assets | -- | -- | -- | -- | -- | $19.5M | -- | ||
PRE-TAX INCOME | |||||||||
EBIT | $-9.9M | $-28.1M | $-39.4M | $-61.9M | $-69.7M | $-142.6M | $-117.1M | ||
Pre-Tax Income | $-9.9M | $-28.1M | $-39.5M | $-62.1M | $-69.8M | $-142.7M | $-117.1M | ||
INCOME TAX | |||||||||
Tax Provision | $26.0K | $19.0K | $-2.8M | $-125.0K | -- | -- | -- | ||
NET INCOME | |||||||||
Net Income | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | ||
Net Income (Continuing Operations) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | ||
Net Income (Discontinued Operations) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | ||
Net Income (Common Stockholders) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | ||
Normalized Income | -- | -- | -- | $-61.0M | -- | -- | -- | ||
TOTALS | |||||||||
Total Expenses | $-62.9M | $32.4M | $57.1M | $71.2M | $97.5M | $152.0M | $127.6M | ||
SHARE & EPS DATA | |||||||||
Average Shares Outstanding | $26.4M | $2.1M | $7.3M | $31.0M | $41.1M | $43.0M | $87.9M | ||
Average Shares Outstanding (Diluted) | $26.5M | $2.1M | $7.3M | -- | $41.1M | $43.0M | $87.9M | ||
Shares Outstanding | $28.1M | $36.4M | $31.8M | $39.9M | $43.0M | $82.2M | $82.7M | ||
Basic EPS | -- | -- | $-5.01 | $-2 | $-1.7 | $-3.31 | $-1.33 | ||
Basic EPS (Continuing Operations) | -- | -- | $-5.01 | $-2 | $-1.7 | $-3.31 | $-1.33 | ||
Diluted EPS | $-1.42 | $-13.15 | $-5.01 | $-2 | $-1.7 | $-3.31 | $-1.33 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-1.7 | $-3.31 | $-1.33 | ||
OTHER METRICS | |||||||||
Gain On Sale Of P P E | -- | -- | -- | -- | $-55.0K | $4.0K | -- | ||
Other Gand A | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | ||
Other Impairment Of Capital Assets | -- | -- | $2.3M | $1.2M | -- | -- | -- | ||
Rent And Landing Fees | $8.6M | $8.7M | -- | -- | -- | -- | -- | ||
Restruct | -- | $113.2M | $35.8M | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ACET | $0.82 | +3.3% | 267.04K |
3 | ||||
4 | ||||
5 | ||||
6 |